Blood-based red marrow dosimetry: where's the beef?
Siegel
Jeffry A
JA
Sparks
Richard B
RB
Sharkey
Robert M
RM
Wessels
Barry W
BW
Bolch
Wesley E
WE
Bouchet
Lionel G
LG
Breitz
Hazel B
HB
Meredith
Ruby F
RF
Sgouros
George
G
Stabin
Michael G
MG
D000328:Adult; D000368:Aged; D000465:Algorithms; D000906:Antibodies / Q000097:blood* / Q000627:therapeutic use; D001853:Bone Marrow / Q000378:metabolism*; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D008955:Models, Cardiovascular; D016499:Radioimmunotherapy / Q000379:methods / Q000592:standards; D011865:Radioisotope Dilution Technique; D011868:Radioisotopes / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D011874:Radiometry / Q000379:methods* / Q000592:standards*; D019275:Radiopharmaceuticals / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D011879:Radiotherapy Dosage / Q000592:standards*; D012211:Rhenium / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D014481:United States
D000906:Antibodies; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D012211:Rhenium